Bank of New York Mellon Corp decreased its position in Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) by 4.7% during ...
Lantheus (NASDAQ:LNTH – Get Free Report) had its price objective lowered by B. Riley from $127.00 to $122.00 in a research report issued on Friday,Benzinga reports. The firm currently has a “buy” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results